U.S. NeuroSurgical Holdings, Inc.
USNU · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | $1 |
| % Margin | – | – | – | 91.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | -$0 | $0 |
| Operating Expenses | $2 | $1 | $1 | $1 |
| Operating Income | -$2 | -$1 | -$1 | -$0 |
| % Margin | – | – | – | -8.3% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$2 | -$1 | -$2 | -$1 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$2 | -$1 | -$2 | -$1 |
| % Margin | – | – | – | -83% |
| EPS | -0.13 | -0.088 | -0.17 | -0.11 |
| % Growth | -47.9% | 48.3% | -54.5% | – |
| EPS Diluted | -0.13 | -0.088 | -0.17 | -0.11 |
| Weighted Avg Shares Out | 15 | 9 | 8 | 8 |
| Weighted Avg Shares Out Dil | 15 | 9 | 8 | 8 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $1 | $0 | $0 |
| EBITDA | -$2 | -$0 | -$1 | -$1 |
| % Margin | – | – | – | -48.5% |